Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy

Affiliations

¹ Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.
² Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington.

Comment

Elisabeth M Sulaica et al. JAMA Cardiol. 2020.

. 2020 Jan 1;5(1):111.

doi: 10.1001/jamacardio.2019.4542.

¹ Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.
² Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington.

No abstract available

Comment in

Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy-Reply.
Harskamp RE, Alexander JH, Lopes RD. Harskamp RE, et al. JAMA Cardiol. 2020 Jan 1;5(1):111-112. doi: 10.1001/jamacardio.2019.4551. JAMA Cardiol. 2020. PMID: 31799984 No abstract available.

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.
Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, Ten Berg JM, Sarafoff N, Gibson CM, Alexander JH. Lopes RD, et al. JAMA Cardiol. 2019 Aug 1;4(8):747-755. doi: 10.1001/jamacardio.2019.1880. JAMA Cardiol. 2019. PMID: 31215979 Free PMC article.